Oxford BioMedica/Sanofi Make Headway With FDA On TroVax Cancer Vaccine

 
• By Jessica Merrill

Drug makers reaffirm commitment to developing TroVax, a therapeutic vaccine for renal cancer and potentially colorectal cancer.

More from Archive

More from Pink Sheet